The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2071 LAMIVIR LAMIVUDINE USP 100 MG TABLET ALU-PVC BLISTER TREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL REPLICATION AND ACTIVE LIVER INFLAMMATION NULL PALAMY PHARMA CO., LTD INCEPTA PHARMACEUTICALS LIMITED BANGLADESH CERTIFICATE RELEASED 05 I 3322/09 23-NOV-2023 22-Nov-2026 View
2072 LAREYA LEFLUNOMIDE 20 MG FILM COATED TABLET ALU-ALU BLISTER FOR THE TREATMENT OF ADULT PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AS A DISEASE MODIFYING ANTIRHEUMATIC DRU, ACTIVE PSORIATIC ARTHRITIS NULL PALAMY PHARMA CO., LTD SRIPRASIT PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 11 I 5649/23 23-NOV-2023 22-Nov-2026 View
2073 LERMEX ACYCLOVIR 200MG TABLET BLISTERPACK FOR TREATMENT OF HERPES SIMPLEX VIRUS NULL PALAMY PHARMA CO., LTD SRIPRASIT PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 04 I 1614/98 18-AUG-2023 17-AUG-2026 View
2074 LIOBAC BACLOFEN 10 MG TABLET ALU-PVC BLISTER FOR THE RELIEF OF SPASTICITY OF VOLUNTARY MUSCLE RESULTINH FROM SUCH DISORDERS AS: MULTIPLE SCLEROSIS, OTHER SPINAL LESIONS, E.G TUMORS OF THE SPINAL CORD, SYRINGOMYELIA, MOTOR NEURONE DISEASE, TRANSVERSE MYELITIS, TRAUMATIC PARTIAL SECTION OF THE CORD NULL PALAMY PHARMA CO., LTD SRIPRASIT PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 03 I 5434/23 31-Mar-2023 30-Mar-2026 View
2075 LIVOX-500 LEVOFLOXACIN HEMIHYDRATE USP 512.495 MG Q.TO ANHYDROUS LEVOFLOXACIN 500MG FILM COATED TABLET ALU -ALU BLISTERPACK ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, COMPLICATED URINARY TRACT INFECTIONS AND ACUTE PYELONEPHRITIS, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, INTRA-ABDOMINAL INFECTIONS NULL PALAMY PHARMA CO., LTD ZEE LABOBORATORIES INDIA CERTIFICATE RELEASED 02 I 2729/06 07-FEB-2024 06-FEB-2027 View
2076 LOFIBRATE 160 FENOFIBRATE 160 MG TABLET STRIP ADJUNCT TO DIETARY THERAPY FOR THE TREATMENT OF ADULTS WITH ELEVATIONS OF SERUM TRIGLYCERIDE LEVELS(TYPES IV AND V HYPERLIPIDEMIA), ADJUNCT TO DIETARY THERAPY FOR THE REDUCTION OF LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C), TOTAL CHOLESTEROL, TRIGLYCERIDES AND APOPROTEIN B IN ADULT PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDERMIA NULL PALAMY PHARMA CO., LTD POLIPHARM CO.,LTD THAILAND CERTIFICATE RELEASED 08 I 5122/21 16-JAN-2025 15-JAN-2030 View
2077 LOSART 50 LOSARTAN POTASSIUM USP 50 MG TABLET ALU-PVC BLISTER HYPERTENSION : LOSART IS INDICATED FOR THE TREATMENT OF HYPERTENSION. HYPERTENTIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY : LOSART IS INDICATED TO REDUCE THE RISK OF STROKE IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY. NULL PALAMY PHARMA CO., LTD THE ACME LABORATORIES LTD. BANGLADESH CERTIFICATE RELEASED 03 I 4218/17 19-MAY-2023 18-MAY-2026 View
2078 LOSART PLUS LOSARTAN POTASSIUM USP 50 MG HYDROCHLOROTHIAZIDE BP 12.5 MG FILM-COATED TABLETS ALU-ALU BLISTER FOR THE TREATMENT OF HYPERTENSION, FOR PATIENTS IN WHOM COMBINATION THERAPY IS APPROPRIATE. NULL PALAMY PHARMA CO., LTD THE ACME LABORATORIES LTD. BANGLADESH CERTIFICATE RELEASED 03 I 3734/12 31-Mar-2023 30-Mar-2026 View
2079 MAFORAN 2 MG WARFARIN SODIUM 2 MG TABLET ALU-ALU BLISTER FOR PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOSIS AND ITS EXTENSION NULL PALAMY PHARMA CO., LTD SRIPRASIT PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 05 I 4450/18 03-MAR-2025 02-MAR-2030 View
2080 MAFORAN 3 MG WARFARIN SODIUM 3 MG TABLET ALU-ALU BLISTER FOR PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOSIS AND ITS EXTENSION NULL PALAMY PHARMA CO., LTD SRIPRASIT PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 05 I 4451/18 03-MAR-2025 02-MAR-2030 View